Olanzapine solvates.

Area of Science:

• Pharmaceutical Chemistry
• Materials Science
• Crystallography

Background:

• Olanzapine is an atypical antipsychotic medication.
• Understanding its solid-state properties, including polymorphism and solvate formation, is crucial for drug formulation and stability.
• Previous studies have explored olanzapine polymorphs, but systematic investigation of solvent effects on solvate formation and subsequent desolvation is needed.

Purpose of the Study:

• To investigate the crystallization of olanzapine from various organic solvents.
• To characterize the resulting solvates and the polymorphic forms of desolvated olanzapine.
• To determine the influence of crystallization conditions on solvate formation and polymorphic outcomes.

Main Methods:

• Crystallization of olanzapine from 12 organic solvents (alone or in mixtures) using cooling, evaporation, or suspension methods.
• Thermal analysis, including differential scanning calorimetry (DSC) and thermogravimetry (TG), to identify solvates, polymorphic forms, and stoichiometry.
• X-ray diffraction analysis for amorphous solvate characterization.

Main Results:

• Solvents were classified into four groups based on DSC thermograms: no solvate formation (form 1), solvate formation followed by form 1, solvate formation followed by form 2, and poorly evident solvate thermograms.
• Most solvents formed solvates in pure form and mixtures; methanol monosolvate showed complex thermal behavior.
• Dichloromethane solvate was amorphous and crystallized into form 1 and/or form 2 upon heating, depending on preparation conditions.

Conclusions:

• The choice of organic solvent significantly impacts olanzapine solvate formation and the polymorphic form of the desolvated drug.
• Thermal analysis (DSC/TG) is effective for characterizing olanzapine solvates and polymorphs.
• Crystallization conditions play a critical role in determining the solid-state properties of olanzapine.